Research map: Broadening the Assessment of Antimicrobial Value: Insights from Two Evaluations of Aztreonam–Avibactam in Spain

Back to the article

Papers in this map

  1. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 · Richard Pitman · 2012 · 233 citations · Cited by this paper
  2. Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity · 2026 · Related
  3. Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria · Nupur Gargate · 2025 · 71 citations · Cited by this paper
  4. Use of Isavuconazole in the Treatment of Cryptococcosis: A Real-World Case Series · 2026 · Related
  5. Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem? · Abigail R. Colson · 2021 · 34 citations · Cited by this paper
  6. Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C · 2026 · Related
  7. New antimicrobials set for UK market through new subscription model · Gareth Iacobucci · 2022 · 4 citations · Cited by this paper
  8. Multicenter Real-World Outpatient Use of Intravenous Omadacycline · 2026 · Related
  9. Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value Framework · Ricard Ferrer · 2025 · 3 citations · Cited by this paper
  10. Early Warning and Behavioural Intervention on the Cardiovascular Disease Risk in People Living with HIV: A Multicentre Non-Randomized Controlled Trial · 2026 · Related
  11. Cost-Effectiveness Analysis of Aztreonam–Avibactam Compared with Colistin Plus Meropenem in Treating Metallo-Beta-Lactamase-Producing Enterobacterales Infections in Spain · Gerardo Aguilar · 2025 · 2 citations · Cited by this paper
  12. HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort · 2026 · Related
  13. Untitled · Cited by this paper
  14. Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis · 2026 · Related
  15. Hospitalisation Burden of Human Metapneumovirus and Respiratory Syncytial Virus in Adults by Age and Comorbidity Status in Scotland: A Retrospective Analysis · 2026 · Related
  16. Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection · 2026 · Related
  17. Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019–2025: Analysis of Nationwide Hospital Data · 2026 · Related

Source: OpenAlex (CC0)